tetrahydrocannabinol/anandamide hybrids (Organix)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametetrahydrocannabinol/anandamide hybrids (Organix)
Drug Alias NameTHC/anandamide hybrids (Organix)cannabinoid CB1 receptor anatgonists (Organix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrganix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrganix Inc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A